학술논문
MCM3 upregulation confers endocrine resistance in breast cancer and is a predictive marker of diminished tamoxifen benefit
Document Type
Artikel
Author
Source
NPJ breast cancer. 7(1):2
Subject
Language
English
English
English
ISSN
2374-4677